Special Drug Use Investigation for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment

Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients

NCT00521885 ·Status: TERMINATED ·Phase: NA

Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal General Surgery

NCT01390896 ·Status: COMPLETED

Effectiveness of Blood Clot Medication With Concomitant Blood Pressure Medication

NCT00424281 ·Status: UNKNOWN

Hemorrhage Risk Prescribed Arixtra

NCT01064362 ·Status: COMPLETED

Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy

NCT00539942 ·Status: TERMINATED ·Phase: PHASE3

Arixtra PE Study- Outpatient Management of Stable Acute Pulmonary Embolism: Once Daily Subcutaneous Fondaparinux

NCT00378027 ·Status: WITHDRAWN

Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism

NCT00413504 ·Status: COMPLETED ·Phase: NA

The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients

NCT00531843 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers

NCT00436787 ·Status: COMPLETED ·Phase: PHASE2

Secondary Prevention of Venous Thrombo Embolism (VTE).

NCT00329238 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients

NCT02213978 ·Status: COMPLETED

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

NCT00790335 ·Status: COMPLETED ·Phase: PHASE3

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

NCT01583218 ·Status: COMPLETED ·Phase: PHASE3

Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis (PREDICTORS)

NCT02297373 ·Status: COMPLETED

Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism

NCT04168203 ·Status: COMPLETED ·Phase: PHASE4

Fondaparinux in Critically Ill Patients With Renal Failure

NCT01467583 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism

NCT00291330 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism

NCT00633893 ·Status: COMPLETED ·Phase: PHASE3

A Study of Adverse Events and Suspected Adverse Drug Reactions of Patients Under Treatment of Apixaban for Venous Thomboembolism (VTE) Treatment

NCT03812835 ·Status: WITHDRAWN

Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism

NCT01004939 ·Status: COMPLETED

Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma Patients

NCT02412982 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of Chemical Venous Thromboembolism Prophylaxis in Trauma

NCT06025162 ·Status: UNKNOWN

Treatment Patterns Among Patients With Venous Thromboembolism in the United States

NCT05795062 ·Status: COMPLETED

Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism

NCT05794165 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2

Comparative Effectiveness and Safety Between Warfarin and Dabigatran

NCT03254134 ·Status: COMPLETED